We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
(Approval lapsed) Atropine Sulphate 1mg/5mL solution for injection pre-filled syringe (Aguettant, UK)
Section 19A approved medicine
(Approval lapsed) Atropine Sulphate 1mg/5mL solution for injection pre-filled syringe (Aguettant, UK)
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 516
Phone
1800 181 060
Approved until
Status
Expired
Indication(s)
Atropine sulfate 0.2 mg/mL, solution for injection in pre-filled syringe is indicated in adults only.
Cardiac:
- In the management of patients with severe bradycardia and bradyarrhythmias to increase the heart rate.
- Patients with Type I atrioventricular conduction deficits to lessen the degree of atrioventricular heart block.
Anaesthesia:
- Atropine is indicated as an antisialogogue in anaesthetic premedication to reduce or prevent secretions in the respiratory tract.
- During anaesthesia, atropine may be used to prevent reflex bradycardia and restore cardiac rate and arterial pressure resulting from the increased vagal activity associated with laryngoscopy, tracheal intubation and intra-abdominal manipulation, and for the prevention of the oculo-cardiac reflex during ophthalmic surgery. It may also be used to block muscarinic effects when neostigmine is used to counter the action of muscle relaxants.
Anticholinesterase poisoning:
Images
